ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer

June 26, 1987

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

Court Order May Clear Way From Big Landow-Blair-Switch

July 6, 1984

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008